{
  "main_header": {
    "sid": 930938,
    "name": "Gennex Lab.",
    "stock_name": "Gennex Lab.",
    "full_name": "Gennex Laboratories Ltd",
    "name_url": "stocks-analysis/gennex-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "8.89",
    "chg": -0.06,
    "chgp": "-0.67%",
    "dir": -1,
    "prev_price": "8.95",
    "mcapval": "218.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531739,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE509C01026",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "3.53 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/gennex-lab-930938-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Gennex Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-gennex-laboratories-ltd-4001748",
        "imagepath": "",
        "date": "2026-05-20 23:19:00",
        "description": "The next results date for Gennex Laboratories Ltd is scheduled for 30 May 2026...."
      },
      {
        "title": "Gennex Laboratories Ltd Valuation Turns Very Attractive Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-valuation-turns-very-attractive-amid-market-pressure-3997830",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GennexLaborator_valuationdot_3997830.png",
        "date": "2026-05-19 08:01:56",
        "description": "Gennex Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite recent share price declines and underperformance relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling value compared to peers and historical averages."
      },
      {
        "title": "Gennex Laboratories Ltd Valuation Shifts to Very Attractive Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-valuation-shifts-to-very-attractive-amid-sector-challenges-3988496",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GennexLaborator_valuationdot_3988496.png",
        "date": "2026-05-13 08:01:21",
        "description": "Gennex Laboratories Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite ongoing challenges in its stock price performance relative to the broader market. This micro-cap pharmaceutical player’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling entry point compared to its historical averages and peer group benchmarks."
      }
    ],
    "total": 15,
    "sid": "930938",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/gennex-laboratories-930938"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Jul-2026",
      "details": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication regarding Meeting of the Board of Directors of the Company scheduled to be held on Friday August 14 2026 for adoption of Unaudited (Standalone and Consolidated) Financial Results for the Quarter ended June 30 2026 along with the Limited Review Report of the Statutory Auditors thereon. Notice had been published in both Business Standard and Saksham (Telugu Local) on July 30 2026. We request you to take the above information on record and acknowledge receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2026.",
      "datetime": "29-Jul-2026",
      "details": "Gennex Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. The Unaudited Financial Statements (Standalone and Consolidated) for the Quarter ended June 30 2026; 2. Consider the Limited Review Reports of the Statutory Auditor on Standalone and Consolidated Financial Statements for the Quarter ended June 30 2026; 3. Other Business items.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "17-Jul-2026",
      "details": "With reference to the captioned subject matter pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the certificate received from the M/s R&D Infotech Private Limited Registrar and Transfer Agent of the Company for the Quarter ended June 30 2026. We request you to take the above information on record and acknowledge the receipt of the same.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:10</strong> stock split, ex-date: 14 Dec 09",
          "dt": "2009-12-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:2</strong> rights issue, ex-date: 21 Jul 22",
          "dt": "2022-07-21",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

When is the next results date for Gennex Laboratories Ltd?

2026-05-20 23:19:00

The next results date for Gennex Laboratories Ltd is scheduled for 30 May 2026....

Read More

Gennex Laboratories Ltd Valuation Turns Very Attractive Amid Market Pressure

2026-05-19 08:01:56

Gennex Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite recent share price declines and underperformance relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling value compared to peers and historical averages.

Read More

Gennex Laboratories Ltd Valuation Shifts to Very Attractive Amid Sector Challenges

2026-05-13 08:01:21

Gennex Laboratories Ltd has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating, despite ongoing challenges in its stock price performance relative to the broader market. This micro-cap pharmaceutical player’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling entry point compared to its historical averages and peer group benchmarks.

Read More

View All News